12 research outputs found

    Nadczynno艣膰 przytarczyc leczona kalcymimetykiem - opis przypadku

    Get PDF
    Nadczynno艣膰 przytarczyc jest jedn膮 z najcz臋stszych postaci klinicznych zaburze艅 mineralno-kostnych towarzysz膮cych przewlek艂ej chorobie nerek. 呕adna ze stosowanych dotychczas metod leczenia tej nieprawid艂owo艣ci (z subtotalnym usuni臋ciem nadczynnych narz膮d贸w w艂膮cznie) nie okaza艂a si臋 w pe艂ni skuteczna. Jednym z wa偶nych sposob贸w hamowania nadmiernej czynno艣ci wydzielniczej przytarczyc jest stosowanie cinakalcetu, leku z grupy kalcymimetyk贸w. Poni偶ej opisano przypadek wt贸rnej nerkowopochodnej nadczynno艣ci przytarczyc leczony kilkoma metodami, w tym tak偶e usuni臋ciem przytarczyc i cinakalcetem

    Binocrit — bionast臋pcza erytropoetyna alfa w leczeniu niedokrwisto艣ci nerkopochodnej

    No full text
    Wraz z up艂ywem ochrony patentowej na leki wytwarzane metodami biotechnologicznymi na rynku farmaceutycznym pojawi艂o si臋 wiele preparat贸w okre艣lanych jako biopodobne lub bionast臋pcze. Szczeg贸lne zainteresowanie nefrolog贸w budzi mo偶liwo艣膰 zastosowania lek贸w bionast臋pczych w terapii niedokrwisto艣ci nerkopochodnej. W niniejszym opracowaniu om贸wiono stan wiedzy na temat profilu farmakokinetycznego i farmakodynamicznego jednego z bionast臋pczych preparat贸w erytropoetyny alfa o nazwie Binocrit oraz jego skuteczno艣膰 i bezpiecze艅stwo w leczeniu pacjent贸w z niedokrwisto艣ci膮 nerkopochodn膮. Omawiany lek charakteryzuje si臋 wysokim profilem bezpiecze艅stwa, a jego skuteczno艣膰 nie odbiega od referencyjnych preparat贸w erytropoetyny. Forum Nefrologiczne 2011, tom 4, nr 3, 277–28

    Type of dialysis access at first dialysis session accordingly with different studied subgroups.

    No full text
    <p>Abbreviations: ER+P, early referral and planned patients; ER+NP, early referral and non-planned patients; LR+P, late referral and planned patients; LR+NP, late referral and non-planned patients. PD, peritoneal dialysis; HD, hemodialysis; AVF, arterio-venous fistula. Figure represents a diagram of bars showing the different types of accesses at first dialysis session. Accesses were as follows for the total population: 34.5% AVF, 8% peritoneal catheter, 8.5% temporal hemodialysis catheter and 49% permanent HD catheter. For ER+P: 77% AVF, 21% peritoneal catheter, no temporal hemodialysis catheter and 2% permanent HD catheter. For ER+NP: 0.8% AVF, 2.6% peritoneal catheter, 9% temporal hemodialysis catheter and 88% permanent HD catheter. For LR+P: 89% AVF, 8% peritoneal catheter, no temporal hemodialysis catheter and 3% permanent HD catheter. For LR+NP: 0.4% AVF, 1% peritoneal catheter, 18% temporal hemodialysis catheter and 80% a permanent HD catheter.</p

    Patients Flowchart for clinical study evaluation.

    No full text
    <p>Abbreviations: ER, early referred patients; LR, late referred patients; P, planned dialysis start patients; NP, non-planned dialysis start patients; ER+P, early referral and planned patients; ER+NP, early referral and non-planned patients; LR+P, late referral and planned patients; LR+NP, late referral and non-planned patients. A total of 626 patients started dialysis in 2012 from 25 Integrated Care Setting Clinics in Poland, Hungary and Romania at Diaverum Renal Services but only 547 were evaluated after excluding patients returning from a previous kidney transplantation (n = 23) and from one center with incomplete data (n = 56). Evaluated patients were primarily divided into two groups according with type of referral being 281 patients ascribed to the early referral and 266 patients into the late referral. Both groups were secondarily divided into another two groups each, depending on type of dialysis start. 168 patients were considered as early referred and with a planned dialysis start, 113 patients were considered as early referred but with a non-planned dialysis start, 63 patients were considered late referred but with planned dialysis start and 203 patients were late referred and had non-planned dialysis start. Planned dialysis patients were 231 of the total population and non-planned dialysis start were 316.</p
    corecore